文献速递头颈外科

赖氨酰氧化酶表达可预测喉癌远处转移

Expression of Lysyl Oxidase Predictive of Distant Metastasis of Laryngeal Cancer.
PubMed 文献 · Otolaryngol Head Neck Surg · 2017-01-24

该回顾性研究纳入100例接受手术治疗的喉癌患者,用免疫组化检测组织芯片中赖氨酰氧化酶(LOX)表达,以评分≤6为低表达组、>6为高表达组。高LOX组总生存率和无复发生存率均较差(P<.05),LOX表达与远处无转移生存率相关(OR=7.72,95%CI:1.02-19.18,P=.048)。

要点

  • 高LOX组总生存率和无复发生存率均较低LOX组差(P<.05)。
  • LOX表达与淋巴结转移呈边缘显著相关。
  • LOX表达与远处无转移生存率相关(OR=7.72,95%CI:1.02-19.18,P=.048)。

核心结论

  • 喉癌中LOX高表达与淋巴结转移、远处转移及不良预后相关。

研究设计与样本

  • 回顾性病历复习与组织学分析,纳入100例接受手术治疗且组织标本可用的喉癌患者。

主要发现

  • LOX主要表达于肿瘤细胞胞质和胞核。
  • Kaplan-Meier分析显示高LOX组总生存率和无复发生存率均较低LOX组差(P<.05)。
  • LOX表达与淋巴结转移呈边缘显著相关。
  • Cox回归分析中,LOX表达与总生存率显著相关(OR=3.92,95%CI:1.35-11.37,P=.012),淋巴结转移与总生存率显著相关(OR=1.96,95%CI:0.93-1.43,P=.024)。
  • LOX表达与远处无转移生存率相关(OR=7.72,95%CI:1.02-19.18,P=.048)。

关键数值与推荐

  • LOX评分≤6归入低LOX组,评分>6归入高LOX组。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective To investigate the prognostic significance of lysyl oxidase (LOX) expression in laryngeal cancer. Study Design Retrospective chart review and histologic analysis. Setting Tertiary referral academic center. Subjects and Methods Patients (N = 100) underwent surgical treatment for laryngeal cancer and had tissue specimens available. Immunohistochemical staining for LOX was performed on laryngeal cancer tissue microarrays, and the proportion and intensity of staining were evaluated. Patients with LOX scores ≤6 were classified into the low LOX group, while those with scores >6 were classified into the high LOX group. We analyzed the correlation between LOX expression and clinical factors as well as prognosis. Results LOX was predominantly expressed in the cytoplasm and nuclei of tumor cells. Kaplan-Meier analysis revealed that the high LOX group had worse overall survival and recurrence-free survival rates than the low LOX group ( P < .05). LOX expression exhibited marginally significant correlation with lymph node metastasis. In the Cox regression analysis, LOX expression and lymph node metastasis were significant factors correlated with overall survival rate (odds ratio [OR] = 3.92, 95% confidence interval [95% CI]: 1.35-11.37, P = .012; OR = 1.96, 95% CI: 0.93-1.43, P = .024, respectively). LOX expression was related to distant metastasis free survival rate (OR = 7.72, 95% CI: 1.02-19.18, P = .048). Conclusion A high expression level of LOX is associated with lymph node and distant metastasis as well as poor prognosis among patients with laryngeal cancer.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Lee YS, Park Y, Kwon M, et al. Expression of Lysyl Oxidase Predictive of Distant Metastasis of Laryngeal Cancer. Otolaryngol Head Neck Surg. 2017. PMID: 28116994. doi:10.1177/0194599816685698

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。